Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 2.05% is 272% above its 5-year average of 0.55%, near the high end of its 5-year range (-5.79%–2.24%).
13.39% above its 12-month average of 1.81%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 2.24%.
NET PROFIT MARGIN
2.05%
NET PROFIT MARGIN AVG TTM
1.81%
NET PROFIT MARGIN AVG 3Y
0.75%
NET PROFIT MARGIN AVG 5Y
0.55%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+13.39%
CURRENT VS 3Y AVG
+172.39%
CURRENT VS 5Y AVG
+272.26%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 397 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
BrightSpring Health Services, Inc. Common Stock
Market Cap
$12.17B
Net Profit Margin
2.05%
TTM Avg
1.81%
3Y Avg
0.75%
5Y Avg
0.55%
Market Cap
$12.00B
Net Profit Margin
10.01%
TTM Avg
9.01%
3Y Avg
7.89%
5Y Avg
8.30%
Market Cap
$12.52B
Net Profit Margin
-9.27%
TTM Avg
-7.30%
3Y Avg
-3.29%
5Y Avg
1.14%
Market Cap
$12.85B
Net Profit Margin
24.86%
TTM Avg
33.22%
3Y Avg
32.75%
5Y Avg
45.02%
Market Cap
$12.89B
Net Profit Margin
3.99%
TTM Avg
6.17%
3Y Avg
6.60%
5Y Avg
6.82%
Market Cap
$12.95B
Net Profit Margin
-97.64%
TTM Avg
-193.35%
3Y Avg
-1980.08%
5Y Avg
-2361.16%
Market Cap
$11.36B
Net Profit Margin
14.97%
TTM Avg
10.50%
3Y Avg
15.15%
5Y Avg
16.71%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BrightSpring Health Services, Inc. Common Stock (BTSG) | $12.17B | 2.05% | 1.81% | 0.75% | 0.55% |
| Encompass Health Corporation (EHC)vs › | $12.00B | 10.01% | 9.01% | 7.89% | 8.30% |
| Penumbra, Inc. (PEN)vs › | $12.49B | 10.67% | 6.92% | 5.54% | 3.35% |
| Baxter International Inc. (BAX)vs › | $12.52B | -9.27% | -7.30% | -3.29% | 1.14% |
| Halozyme Therapeutics, Inc. (HALO)vs › | $12.85B | 24.86% | 33.22% | 32.75% | 45.02% |
| DaVita Inc. (DVA)vs › | $11.47B | 6.05% | 6.39% | 5.83% | 6.41% |
| ICON Public Limited Company (ICLR)vs › | $12.89B | 3.99% | 6.17% | 6.60% | 6.82% |
| BridgeBio Pharma, Inc. (BBIO)vs › | $12.95B | -97.64% | -193.35% | -1980.08% | -2361.16% |
| Bio-Techne Corporation (TECH)vs › | $11.36B | 14.97% | 10.50% | 15.15% | 16.71% |
| Corcept Therapeutics Incorporated (CORT)vs › | $13.19B | 6.61% | 16.89% | 20.26% | 23.62% |
Operating Margin
3.3%
Net Profit Margin
2.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 2.24% |
| 2026-03-31 | 2.06% |
| 2025-12-31 | 2.17% |
| 2025-09-30 | 1.67% |
| 2025-06-30 | 0.90% |
| 2025-03-31 | 1.03% |
| 2024-12-31 | 0.52% |
| 2024-09-30 | -0.28% |
| 2024-06-30 | 0.82% |
| 2024-03-31 | -2.00% |
| 2023-12-31 | -0.28% |
| 2023-09-30 | -5.79% |
| 2023-06-30 | 0.18% |
| 2023-03-31 | -1.05% |
| 2022-12-31 | -2.85% |
| 2022-09-30 | -1.15% |
| 2022-06-30 | 0.66% |
| 2022-03-31 | 0.66% |
| 2021-12-31 | 0.83% |
| 2021-09-30 | 0.96% |
| 2021-06-30 | 0.51% |
| 2021-03-31 | 0.67% |
| 2020-12-31 | -0.03% |
| 2020-09-30 | 1.03% |
| 2020-06-30 | 0.25% |
| 2020-03-31 | 0.25% |
| 2019-12-31 | -1.73% |
| 2019-09-30 | 0.08% |
| 2019-06-30 | -0.44% |
